Stanford Medicine researchers have discovered a previously unknown metabolic pathway and family of "keto" metabolites, potentially revolutionizing our understanding of ketosis. Led by Jonathan Long, the research team found that beyond the known processes of ketogenesis and ketolysis, there exists a third "shunt pathway" where enzymes attach beta-hydroxybutyrate (BHB) to amino acids, creating compounds called BHB-amino acids. This discovery challenges the previous understanding that ketosis was a simple, monolithic state.
The researchers found that these newly discovered BHB-amino acids play an active role in suppressing appetite and promoting weight loss during ketosis. This finding helps explain why people often experience reduced hunger when fasting or following a ketogenic diet. The team is now investigating whether this pathway might be relevant to epilepsy treatment, as the ketogenic diet is known to help control seizures in children with drug-resistant epilepsy. This discovery, published in Cell in November 2024, opens new possibilities for developing treatments that could replicate the benefits of ketosis without requiring strict dietary restrictions.

